Author of the publication

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

, , , , and . International Journal of Antimicrobial Agents, 55 (4): 105932 (2020)
DOI: https://doi.org/10.1016/j.ijantimicag.2020.105932

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards, , , , , , , and . European Journal of Clinical Microbiology & Infectious Diseases, 39 (6): 1059--1061 (Jun 1, 2020)Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates, , , , , , , and . Clinical Infectious Diseases, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , and 4 other author(s). New Microbes and New Infections, (2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, , , and . International Journal of Antimicrobial Agents, 55 (5): 105938 (2020)Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France, , , , , , , , , and 27 other author(s). (2020)Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, , , , and . International Journal of Antimicrobial Agents, 55 (4): 105932 (2020)Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier), , , , , , and . (2020)Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century, , and . International Journal of Antimicrobial Agents, 30 (4): 297 - 308 (2007)